Japan approves two more COVID vaccines as fourth infection wave hitsJapan has approved two more coronavirus vaccines, while expanding a state of emergency to cover the southern island Share XJapan approves two more COVID vaccines as fourth infection wave hitshttps://pharmaphorum.com/news/japan-approves-two-more-covid-vaccines-as-fourth-infection-wave-hits/
Sanofi/GSK move latecomer COVID-19 shot into phase 3Sanofi and GlaxoSmithKline seem to be getting somewhere with their COVID-19 vaccine at last, announcing plans to move Share XSanofi/GSK move latecomer COVID-19 shot into phase 3https://pharmaphorum.com/news/sanofi-gsk-move-latecomer-covid-19-shot-into-phase-3/
Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacyFollowing the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results Share XOxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacyhttps://pharmaphorum.com/news/oxfords-malaria-shot-set-for-phase-3-test-after-unprecedented-77-efficacy/
England begins Moderna vaccine rollout as lockdown easesEngland is beginning its rollout of the Moderna COVID-19 vaccine, offering an alternative to the AstraZeneca/Oxford University jab Share XEngland begins Moderna vaccine rollout as lockdown easeshttps://pharmaphorum.com/news/england-begins-moderna-vaccine-rollout-as-lockdown-eases/
Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trialAntios has raised $96 million in Series B financing to support the ongoing phase 2 development of its Share XRace for hepatitis B drug intensifies as Antios raises $96m for phase 2 trialhttps://pharmaphorum.com/news/race-for-hepatitis-b-drug-intensifies-as-antios-raises-96m-for-phase-2-trial/
South African variant may evade Pfizer/BioNTech vaccine, study findsThe coronavirus variant discovered in South Africa may evade Pfizer/BioNTech’s vaccine, according to a real-world data study conducted Share XSouth African variant may evade Pfizer/BioNTech vaccine, study findshttps://pharmaphorum.com/news/south-african-variant-may-evade-pfizer-biontech-vaccine-study-finds/
Regeneron’s antibody cocktail hits target in COVID prevention studyRegeneron is to ask the FDA for clearance to use its antibody cocktail as a preventive treatment for Share XRegeneron’s antibody cocktail hits target in COVID prevention studyhttps://pharmaphorum.com/news/regeneron-to-ask-fda-to-c/
Regeneron’s antibody cocktail cuts COVID hospitalisation in large trialRegeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk Share XRegeneron’s antibody cocktail cuts COVID hospitalisation in large trialhttps://pharmaphorum.com/news/regenerons-antibody-cocktail-cuts-covid-hospitalisation-in-large-trial/
Pfizer begins clinical trials of COVID-19 antiviral pillPfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at Share XPfizer begins clinical trials of COVID-19 antiviral pillhttps://pharmaphorum.com/news/pfizer-begins-clinical-trials-of-covid-19-antiviral-pill/
